Revvity is at the forefront of innovation in the field of newborn screening, dedicated to improving the health outcomes of newborns through early detection and intervention. Our Turku Site, home to over 500 employees, is a key hub for manufacturing and product development in newborn, maternal fetal health, and prenatal screening. As the global market leader in newborn screening, our solutions have tested over 700 million babies worldwide for life-threatening diseases, making a significant impact on global health.
This is a six month fixed-term contract beginning in January 2025.
Key responsibilities:
Responsibilities are in supporting products which are released to market:
Responsibilities for product releases on instrument manufacturing.
Handling of customer complaints specifically for instrument/software products, including customer communication.
Assist in the preparation, documentation and follow-up for non-conformances andCorrective Action/Preventive Action.
Participate in market withdrawal and medical device reporting activities.
Create, revise, review, and approve quality-related documents, including SOPs, plans, and reports.
Track and trend quality-related data, including but not limited to customer complaints.
Conduct training on quality-related topics for staff in the QA and other departments.
Working closely in cooperation with the Turku Site and as part of the global Quality team.
Role requirements:
B.Sc. or M.Sc. degree in Engineering, Computer Sciences, Bio/Health technology, or corresponding.
Experience in working in sustainable Quality Systems, preferably ISO 13485, QSR or Pharma experience is also appreciated.
Effective cooperation and influencing skills, ability to work independently in a fast-paced environment.
Good written and verbal communication skills both in Finnish and English are essential.
Revvity Turku Site is a drug free site and a medical examination for new employees includes a drug test.
#LI-EMEA